Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”The 49th Annual Conference of the Mumbai Hematology Group (MHG) 2026 and Essence of ASH 2025, held from 24th–26th January 2026 at Bombay Hospital, Mumbai, was truly an enriching and memorable experience.
An outstanding scientific program featuring eminent international and national speakers, dedicated faculty, and enthusiastic delegates—along with exceptional participation from across India in award orals and poster presentations—made this conference truly special.
Beyond the science, the conference offered invaluable opportunities for networking, reconnecting with colleagues, and sharing moments with friends and loved ones, making the experience even more meaningful.
I am deeply honored to serve as Secretary of MHG and to have had the privilege of conducting both the Inaugural and Valedictory sessions.
It was especially meaningful to speak on a topic close to my heart—Health Technology Assessment (HTA) for drugs, focusing on Emicizumab and Extended Half-Life (EHL) therapies in hemophilia, undertaken in collaboration with NHM, DHR, and ICMR.
Closing the conference by recognizing award winners and expressing gratitude to everyone who contributed was the perfect conclusion to an exceptional meeting.
An absolutely fantastic conference—made possible by teamwork, science, and shared connections.
And now, the countdown begins!
MHG turns 50—golden and fabulous
22–24 January 2027 | Golden Jubilee Conference
Save the dates!”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke